Unraveling the Mysteries of the Immune System
In late 2019, as the world started to hear whispers of an emerging virus in China, Priyamvada Acharya, PhD, as
Duke Human Vaccine Institute researchers study a pan vaccine for all types of coronaviruses.
Duke Human Vaccine Institute researchers are featured on the PBS NC series SCI NC and explain the work that goes into creating a vaccine that can protect us against all potential coronaviruses
Closing in on an HIV vaccine using rare antibodies
A rare type of antibody found in some individuals could help develop an HIV vaccine to target highly diverse viral strains.
Four Things to Know About Cryo-EM at Duke
The Cryo-EM microscope has taken over as the main method that Priyamvada Acharya, PhD, director of Duke's new federally funded
The Impact of Science: Duke Researcher Helps Develop Vaccines and Young Minds
Kevin Saunders explains the technology he used when COVID-19 hit, “We thought of creating a vaccine with properties that the current vaccines lacked.”
These Vaccines Will Take Aim at COVID and Its Entire SARs Lineage
Another vaccine poised to enter human clinical trials is being developed by biologist Kevin Saunders and colleagues at the Duke Human Vaccine Institute, who
While All Eyes Were on Covid, HIV Researchers Were Making Progress on “The Holy Grail of Vaccines”
Dr. Barton Haynes, Director of the Duke Human Vaccine Institute, discusses the links between COVID and finding a vaccine for HIV. Read about it in this Mother Jones article.
Duke Awarded Federal Grant to Build Structural Models of HIV
Researchers at the Duke Human Vaccine Institute (DHVI) received a federal grant totaling more than $27 million over five years to focus on building st
